Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone

Journal of Bone and Mineral Metabolism

Volumn 22, Issue 3, 2004, Pages 176-184

  Nampei, Akihide ^a   Hashimoto, Jun ^a   Hayashida, Kenji ^a   Tsuboi, Hideki ^a   Shi, Kenrin ^a   Tsuji, Isamu ^c   Miyashita, Hideaki ^c   Yamada, Takao ^c   Matsukawa, Naomichi ^a   Matsumoto, Masayuki ^b   Morimoto, Shigeto ^b   Ogihara, Toshio ^a   Ochi, Takahiro ^a   Yoshikawa, Hideki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Human; Immunohistochemistry; MEPE; Mineralization; Osteocyte

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; MATRIX PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BONE MINERALIZATION; BONE TISSUE; EXTRACELLULAR MATRIX; GLYCOSYLATION; HUMAN; HUMAN TISSUE; HYPOPHOSPHATEMIA; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; OSTEOBLAST; OSTEOCYTE; OSTEOMALACIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TISSUE SECTION;

ANIMALS; BLOTTING, WESTERN; BONE AND BONES; CHO CELLS; CRICETINAE; ESCHERICHIA COLI; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IMMUNE SERA; OSTEOCYTES; OSTEOMALACIA; OSTEOPOROSIS; PHOSPHOPROTEINS; RECOMBINANT PROTEINS;

EID: 2442675051     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-003-0468-9     Document Type: Article

References (40)

1. Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL (2000) MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67:54-68
2. De Beur SM, Finnegan RB, Vassiliadis J, Cook B, Barberio D, Estes S, Manavalan P, Petroziello J, Madden SL, Cho JY, Kumar R, Levine MA, Schiavi SC (2002) Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 17:1102-1110
3. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280:460-465
4. Petersen DN, Tkalcevic GT, Mansolf AL, Rivera-Gonzalez R, Brown TA (2000) Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem 275:36172-36180
5. Argiro L, Desbarats M, Glorieux FH, Ecarot B (2001) Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 74:342-351
6. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA (2003) Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:1998-2007
7. Kawai Y, Morimoto S, Sakaguchi K, Yoshino H, Yotsui T, Hirota S, Inohara H, Nakagawa T, Hattori K, Kubo T, Yang J, Fujiwara N, Ogihara T (2001) Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP. J Bone Miner Metab 19:61-64
8. Derkx P, Nigg AL, Bosman FT, Birkenhager-Frenkel DH, Houtsmuller AB, Pols HA, van Leeuwen JP (1998) Immunolocalization and quantification of noncollagenous bone matrix proteins in methylmethacrylate-embedded adult human bone in combination with histomorphometry. Bone 22:367-373
9. Aarden EM, Burger EH, Nijweide PJ (1994) Function of osteocytes in bone. J Cell Biochem 55:287-299
10. Nijweide PJ, Burger EH, Klein-Nulend J (2002) The osteocyte. In: Bilezikian J, Raisz L, Rodan G (eds) Principles of Bone Biology, 2nd edn. Academic, San Diego, pp 93-107
11. Fisher LW, Hawkins GR, Tuross N, Termine JD (1987) Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem 262:9702-9708
12. Franzen A, Heinegard D (1985) Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 232:715-724
13. Mark MP, Butler WT, Prince CW, Finkelman RD, Ruch JV (1988) Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone gamma-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation 37:123-136
14. Mark MP, Prince CW, Oosawa T, Gay S, Bronckers AL, Butler WT (1987) Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. J Histochem Cytochem 35:707-715
15. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, Bhown M, Schrohenloher RE (1987) Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 262:2900-2907
16. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (1990) cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 7:491-502
17. Boivin G, Morel G, Lian JB, Anthoine-Terrier C, Dubois PM, Meunier PJ (1990) Localization of endogenous osteocalcin in neonatal rat bone and its absence in articular cartilage: effect of warfarin treatment. Virchows Arch A Pathol Anat Histopathol 417:505-512
18. Hauschka PV, Lian JB, Gallop PM (1975) Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 72:3925-3929
19. Ohta T, Mori M, Ogawa K, Matsuyama T, Ishii S (1989) Immunocytochemical localization of BGP in human bones in various developmental stages and pathological conditions. Virchows Arch A Pathol Anat Histopathol 415:459-466
20. Chen J, Zhang Q, McCulloch CA, Sodek J (1991) Immunohistochemical localization of bone sialoprotein in foetal porcine bone tissues: comparisons with secreted phosphoprotein 1 (SPP-1, osteopontin) and SPARC (osteonectin). Histochem J 23:281-289
21. Chen JK, Shapiro HS, Wrana JL, Reimers S, Heersche JN, Sodek J (1991) Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 11:133-143
22. Oldberg A, Franzen A, Heinegard D (1988) The primary structure of a cell-binding bone sialoprotein. J Biol Chem 263:19430-19432
23. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG (1990) Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549-1563
24. Ibaraki K, Termine JD, Whitson SW, Young MF (1992) Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J Bone Miner Res 7:743-754
25. Ingram RT, Clarke BL, Fisher LW, Fitzpatrick LA (1993) Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res 8:1019-1029
26. Jundt G, Berghauser KH, Termine JD, Schulz A (1987) Osteonectin-a differentiation marker of bone cells. Cell Tissue Res 248:409-415
27. D'Souza RN, Cavender A, Sunavala G, Alvarez J, Ohshima T, Kulkarni AB, MacDougall M (1997) Gene expression patterns of murine dentin matrix protein 1 (Dmp1) and dentin sialophosphoprotein (DSPP) suggest distinct developmental functions in vivo. J Bone Miner Res 12:2040-2049
28. MacDougall M, Gu TT, Luan X, Simmons D, Chen J (1998) Identification of a novel isoform of mouse dentin matrix protein 1: spatial expression in mineralized tissues. J Bone Miner Res 13:422-431
29. Toyosawa S, Shintani S, Fujiwara T, Ooshima T, Sato A, Ijuhin N, Komori T (2001) Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res 16:2017-2026
30. Robey PG (1996) Vertebrate mineralized matrix proteins: structure and function. Connect Tissue Res 35:131-136
31. Aarden EM, Nijweide PJ, van der Plas A, Alblas MJ, Mackie EJ, Horton MA, Helfrich MH (1996) Adhesive properties of isolated chick osteocytes in vitro. Bone 18:305-313
32. Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E (2000) Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest 105:915-923
33. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452
34. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101-1111
35. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20:78-82
36. Yoshitake H, Rittling SR, Denhardt DT, Noda M (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156-8160
37. Nijweide PJ, Mulder RJ (1986) Identification of osteocytes in osteoblast-like cell cultures using a monoclonal antibody specifically directed against osteocytes. Histochemistry 84:342-347
38. Nijweide PJ, van der Plas A, Olthof AA (1988) Osteoblastic differentiation. Ciba Found Symp 136:61-77
39. Bruder SP, Caplan AI (1990) Terminal differentiation of osteogenic cells in the embryonic chick tibia is revealed by a monolclonal antibody against osteocytes. Bone 11:189-198
40. Westbroek I, De Rooij KE, Nijweide PJ (2002) Osteocyte-specific monoclonal antibody MAb OB7.3 is directed against Phex protein. J Bone Miner Res 17:845-853